scholarly article | Q13442814 |
P50 | author | Moustapha Kassem | Q6926286 |
Li Chen | Q61264635 | ||
Jean-Marie Delaissé | Q67738373 | ||
Basem M. Abdallah | Q39754711 | ||
Daniel Hesselson | Q42580532 | ||
P2093 | author name string | Sundeep Khosla | |
Thomas L Andersen | |||
Yuxi Zhang | |||
Stuart Parsons | |||
Nicholas Ditzel | |||
Abbas Jafari | |||
Diyako Qanie | |||
Benno Postert | |||
Per Kjærsgaard-Andersen | |||
Rigmor Solberg | |||
Harald Thidemann Johansen | |||
P2860 | cites work | Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation | Q27678659 |
Stages of embryonic development of the zebrafish | Q27860947 | ||
Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins | Q28306140 | ||
Asparagine endopeptidase is required for normal kidney physiology and homeostasis | Q28507681 | ||
Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells | Q28587171 | ||
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. | Q29347247 | ||
Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. | Q29347297 | ||
Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition | Q30502880 | ||
Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption | Q30773401 | ||
Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain | Q34127426 | ||
Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study | Q34132522 | ||
Novel candidate genes in unstable areas of human atherosclerotic plaques. | Q51585538 | ||
Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. | Q51629480 | ||
Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. | Q52119168 | ||
The balance of osteogenic and adipogenic differentiation in human mesenchymal stem cells by matrices that mimic stepwise tissue development. | Q52619554 | ||
Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. | Q53579321 | ||
Legumain protein as a potential predictive biomarker for Asian patients with breast carcinoma. | Q53633144 | ||
Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M. | Q54050012 | ||
Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer. | Q54317876 | ||
Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. | Q64885339 | ||
Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresis | Q78198089 | ||
Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women | Q79762888 | ||
Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations | Q82550731 | ||
Extracellular matrix protein mediated regulation of the osteoblast differentiation of bone marrow derived human mesenchymal stem cells | Q84289455 | ||
Legumain expression, activity and secretion are increased during monocyte-to-macrophage differentiation and inhibited by atorvastatin | Q85283532 | ||
ptk7 mutant zebrafish models of congenital and idiopathic scoliosis implicate dysregulated Wnt signalling in disease | Q34138284 | ||
An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. | Q34485526 | ||
Expression of legumain correlates with prognosis and metastasis in gastric carcinoma | Q34984213 | ||
Pharmacological Inhibition of Protein Kinase G1 Enhances Bone Formation by Human Skeletal Stem Cells Through Activation of RhoA-Akt Signaling | Q35598732 | ||
Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF. | Q36095068 | ||
Rapid reverse genetic screening using CRISPR in zebrafish | Q36341911 | ||
Matrix metalloproteinases and tumor metastasis | Q36471104 | ||
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
Human mesenchymal stem cells: from basic biology to clinical applications. | Q36996120 | ||
A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas | Q37267313 | ||
Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity. | Q37349204 | ||
Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interference | Q37415413 | ||
Osteoporosis: social and economic impact | Q37770703 | ||
The reversal phase of the bone-remodeling cycle: cellular prerequisites for coupling resorption and formation | Q38239680 | ||
Temporal profiling and pulsed SILAC labeling identify novel secreted proteins during ex vivo osteoblast differentiation of human stromal stem cells. | Q38323561 | ||
Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasis | Q39017137 | ||
Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. | Q40481324 | ||
Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase | Q40784522 | ||
Zebrafish models of idiopathic scoliosis link cerebrospinal fluid flow defects to spine curvature | Q41542474 | ||
Structure and mechanism of an aspartimide-dependent peptide ligase in human legumain | Q41957539 | ||
Decreased biosynthesis of actin and cellular fibronectin during adipose conversion of 3T3-F442A cells. Reorganization of the cytoarchitecture and extracellular matrix fibronectin | Q42800495 | ||
Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes | Q42820082 | ||
Nucleoplasmic calcium regulates cell proliferation through legumain | Q42832634 | ||
Regulation of fibronectin, integrin and cytoskeleton expression in differentiating adipocytes: inhibition by extracellular matrix and polylysine | Q42834581 | ||
Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells | Q43251440 | ||
Legumain and cathepsin-L expression in human unstable carotid plaque. | Q43293933 | ||
Understanding coupling between bone resorption and formation: are reversal cells the missing link? | Q43405568 | ||
Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment | Q43755563 | ||
The effect of fibrinogen, collagen type I, and fibronectin on mesenchymal stem cell growth and differentiation into osteoblasts | Q44161706 | ||
Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. | Q44463026 | ||
Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. | Q46292337 | ||
Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis | Q46673284 | ||
Radiographic analysis of zebrafish skeletal defects | Q47074000 | ||
Assessment of bone formation capacity using in vivo transplantation assays: procedure and tissue analysis | Q47722958 | ||
The bradford method for protein quantitation | Q47766348 | ||
Tracking gene expression during zebrafish osteoblast differentiation. | Q48862114 | ||
Osteoblast recruitment routes in human cancellous bone remodeling. | Q50481118 | ||
Increased levels of legumain in plasma and plaques from patients with carotid atherosclerosis. | Q51274687 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | osteoporosis | Q165328 |
P304 | page(s) | 373-386 | |
P577 | publication date | 2017-02-02 | |
P1433 | published in | Stem Cell Reports | Q27725039 |
P1476 | title | Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis | |
P478 | volume | 8 |
Q64944461 | Bone Marrow Adipose Tissue and Skeletal Health. |
Q92699885 | Brief Report From the 3rd International Meeting on Bone Marrow Adiposity (BMA 2017) |
Q64068044 | Convergence of TGFβ and BMP signaling in regulating human bone marrow stromal cell differentiation |
Q92801341 | Enhancement of Mesenchymal Stem Cell-Driven Bone Regeneration by Resveratrol-Mediated SOX2 Regulation |
Q61796570 | KIAA1199 is a secreted molecule that enhances osteoblastic stem cell migration and recruitment |
Q64892923 | Legumain Promotes Atherosclerotic Vascular Remodeling. |
Q64066251 | Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway |
Q91388275 | Metabolic programming determines the lineage-differentiation fate of murine bone marrow stromal progenitor cells |
Q48262427 | Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains |
Q33752135 | Suppression of asparaginyl endopeptidase attenuates breast cancer-induced bone pain through inhibition of neurotrophin receptors |
Q61806983 | Zebrafish as an Emerging Model for Osteoporosis: A Primary Testing Platform for Screening New Osteo-Active Compounds |
Search more.